Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Frontline”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02283749
What this trial is testing

BrUOG L301 With Non-Small Cell Lung Cancer and Bone Metastases

Who this might be right for
Non Small Cell Lung Cancer With Bone Metastatses
Angela Taber MD 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03755804
What this trial is testing

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Who this might be right for
Hodgkin Lymphoma
St. Jude Children's Research Hospital 232
Not applicableUnknownNCT04150471
What this trial is testing

Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myelocytic Leukemia
Seoul St. Mary's Hospital 79
Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Not applicableStudy completedNCT06823765
What this trial is testing

Can Feedback From a Large Language Model Improve Health Care Quality?

Who this might be right for
All Conditions
Yale University 491
Not applicableStudy completedNCT05104827
What this trial is testing

Integrative Medicine Impact on Frontline COVID-19 Personnel Wellbeing

Who this might be right for
Wellbeing of Healthcare Providersin Frontline COVID-19 Departments
Carmel Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT03242460
What this trial is testing

The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed and/or refractorY Multiple Myeloma
Kosin University Gospel Hospital 55
Testing effectiveness (Phase 2)Ended earlyNCT02906696
What this trial is testing

Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure

Who this might be right for
Blasts Under 15 Percent of Bone Marrow Nucleated CellsBlasts Under 15 Percent of Peripheral Blood White CellsBlasts Under 30 Percent of Bone Marrow Nucleated Cells+2 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT05977673
What this trial is testing

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 28
Early research (Phase 1)Active Not RecruitingNCT03932409
What this trial is testing

Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Oklahoma 45
Not applicableNot Yet RecruitingNCT07506967
What this trial is testing

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Who this might be right for
Skin and Connective Tissue DiseasesNeglected Tropical DiseasesLeprosy+10 more
Kenya Medical Research Institute 2,420
Testing effectiveness (Phase 2)Study completedNCT03023878
What this trial is testing

Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma

Who this might be right for
High-risk Diffuse Large B-Cell Lymphoma
Amgen 47
Testing effectiveness (Phase 2)Looking for participantsNCT06186648
What this trial is testing

Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome

Who this might be right for
Richter Syndrome
French Innovative Leukemia Organisation 40
Testing effectiveness (Phase 2)Study completedNCT00523848
What this trial is testing

Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 46
Testing effectiveness (Phase 2)Looking for participantsNCT06636552
What this trial is testing

An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L

Who this might be right for
Primary Plasma Cell Leukemia
Hellenic Society of Hematology 43
Large-scale testing (Phase 3)Ended earlyNCT04374942
What this trial is testing

Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?

Who this might be right for
Pre-Exposure ProphylaxisCoronavirusSARS-CoV 2
Megan Landes 13
Not applicableStudy completedNCT05122637
What this trial is testing

Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Stroke Patients

Who this might be right for
Acute Ischemic Stroke
RapidPulse, Inc 80
Not applicableStudy completedNCT04723576
What this trial is testing

Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Healthy
RAND 7,444
Large-scale testing (Phase 3)Study completedNCT01639001
What this trial is testing

Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Pfizer 207
Testing effectiveness (Phase 2)UnknownNCT00628238
What this trial is testing

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaCLLUntreated+3 more
Chronic Lymphocytic Leukemia Research Consortium 80
Next Page